INTERNATIONAL PATENT: JANSSEN PHARMACEUTICA NV FILES APPLICATION FOR "SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS"

GENEVA, April 6 -- JANSSEN PHARMACEUTICA NV (Turnhoutseweg 302340 Beerse) filed a patent application (PCT/EP2024/077033) for "SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS" on Sep 26, 2024. With publication no. WO/2025/068354, the details related to the patent application was published on Apr 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): STANSFIELD, Ian (c/o Janssen Pharmaceutica NVTurnhoutseweg 302340 Beerse), DE BOECK, Benoît Christian Albert (c/o Janssen Pharmaceutica NVTurnhoutseweg 302340 Beerse), SALACZ, Laura (c/o Janssen Pharmaceutica NVTurnhouts...